PATENT CLAIM ANALYSIS

Application Number: 15764969
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["435", "006100"]

Abstract:
Therapeutic treatments for cancer based on mutations in the TP53 gene are disclosed, including pharmaceutical corn-positions and methods of using pharmaceutical compositions for treating a disease, in particular a cancer. Diagnostic methods for determining mutations in the TP53 gene are also disclosed.

Claim (Index 8):
The method of  claim 1 , wherein the active pharmaceutical ingredient is a platinum drug, and wherein the platinum drug is selected from the group consisting of cisplatin, carboplatin, oxaliplatin, satraplatin, picoplatin, nedaplatin, triplatin tetranitrate, lipoplatin (liposomal cisplatin), and pharmaceutically acceptable salts, solvates, hydrates, cocrystals, or prodrugs thereof.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 90.0
- Lexical Diversity: 1.53333
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15319740', '15112968', '15101864', '15516780', '13403856']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6606955211303804
- 35 USC 102 Novelty (BERT): 0.5015220805159746
- Combined Prediction Score: 0.6447781770689399
- Mean Citation Score: 218.288076
- Max Citation Score: 231.69904
- Similarity Product: 141.60773563396455

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test